Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2014


Immunology - A Pathway Through the Maze

29 Apr 2014 - 30 Apr 2014 - Department for Continuing Education, Oxford



Bookmark and Share


Immunology is a rapidly developing subject with wide-ranging implications for the pharmaceutical, healthcare and biotechnology industries.

Common questions include, for example: How does the immune system defend the body against infection? What goes wrong when autoimmunity develops? How can undesirable responses be controlled?

Team leaders, R&D directors, and researchers at the bench all need to understand the latest developments in immunology and their implications for drug discovery and development as well as disease treatment. An understanding of the fundamental features of the immune system is essential not only for those who work in areas directly related to infection and immunity, but also for those working in the development of biopharmaceuticals, vaccines and antibody therapy, who wish to exploit the technological advances that have resulted from our increased insight into how the system functions.

As well as offering a path through the immunology maze, the course will emphasize the R&D opportunities for therapeutic intervention that arise from recent advances in immunology, for example the use of therapeutic antibodies and recombinant molecules as potential drug treatments. After the introductory session, each lecture will begin by covering the basic concepts of a particular area of immunology; these will then be developed in such a way that participants are rapidly brought an understanding of the most recent findings.

Oxford is a leading centre in the creative development and application of the theory and techniques of immunology in collaboration with industry. The presenters are leading scientists in their fields and use these techniques in their day-to-day research. They work in the Nuffield Department of Surgery at the University of Oxford.



Further information
Scientific News
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Getting a Better Look at How HIV Infects and Takes Over its Host Cells
A new approach, developed by a team of researchers led by The Rockefeller University and The Aaron Diamond AIDS Research Center (ADARC), offers an unprecedented view of how a virus infects and appropriates a host cell, step by step.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!